This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Coltivirus | |
|---|---|
| Name | Coltivirus |
| Virus group | Reoviridae |
| Familia | Reoviridae |
| Diseases | Colorado tick fever, other febrile illnesses |
Coltivirus is a genus of double-stranded RNA viruses associated with tick-borne febrile illness and encephalitis in humans and animals. Descriptions of related agents involve ecological studies, vector ecology, clinical case series and molecular phylogenetics reported by investigative teams at public health agencies and academic centers. Research on these viruses intersects with field studies in Colorado, laboratory virology at institutions like the Centers for Disease Control and Prevention and molecular comparisons with other members of the Reoviridae family.
Coltiviruses belong to the family Reoviridae and historically were placed within groups defined by serology and genome segmentation, a schema refined by taxonomists at the International Committee on Taxonomy of Viruses and comparative studies from laboratories in Japan and the United States. Early isolates such as the prototype agent described in epidemiologic reports from the United States informed placement relative to genera that include orbiviruses studied by teams at the University of Oxford and bunyaviruses characterized at the London School of Hygiene & Tropical Medicine. Molecular phylogenetic analyses link coltiviruses to clades resolved in publications from the National Institutes of Health and university centers in Europe.
Coltiviruses are non-enveloped particles with a segmented, double-stranded RNA genome similar in architecture to other Reoviridae members analyzed in structural studies at the Max Planck Institute and cryo-electron microscopy facilities at the European Molecular Biology Laboratory. Genome segments encode structural proteins comparable to those investigated by groups at the Scripps Research Institute and nonstructural proteins implicated in replication described in articles from the Journal of Virology and research teams at Harvard Medical School. Comparative genomics with viruses characterized at the Pasteur Institute and sequence databases curated by the National Center for Biotechnology Information reveal conserved motifs and segment reassortment dynamics that parallel observations in studies from the University of Tokyo.
Transmission typically involves ixodid ticks as vectors, with ecological investigations by entomologists at the Smithsonian Institution and field teams from state public health departments documenting tick-host associations in regions such as Colorado, Montana, and provinces investigated by Canadian health agencies. Reservoir studies implicate small mammals reported in ecological literature from the Rocky Mountains and wildlife surveillance coordinated with the United States Geological Survey and conservation organizations. Outbreak investigations have involved collaborations among clinical centers at the Mayo Clinic, regional public health laboratories, and international partners such as the World Health Organization when surveillance identified novel or imported cases.
Human infection can produce an acute febrile syndrome with myalgia, headache, and leukopenia described in clinical series reported from hospitals like those affiliated with Stanford University and case reports compiled by specialty societies in Infectious Diseases Society of America. Severe manifestations include meningoencephalitis documented in neuropathology studies at the National Institutes of Health and neuroimaging reports from tertiary centers such as Johns Hopkins Hospital. Pathogenesis investigations draw on immunology research at institutes like the Rockefeller University and animal model work conducted at university veterinary schools in Canada and the United Kingdom.
Diagnosis combines serology, virus isolation, and nucleic acid detection techniques standardized in reference laboratories at the Centers for Disease Control and Prevention and clinical virology units at universities including Yale School of Medicine. Serologic assays referenced in guidelines from the American Society for Microbiology and molecular PCR protocols published by research groups at the University of California, San Francisco facilitate identification, while next-generation sequencing performed at core facilities at the Wellcome Trust Sanger Institute aids in characterizing novel strains. Biosafety recommendations follow frameworks issued by agencies such as the Occupational Safety and Health Administration and national public health institutes.
There is no specific antiviral therapy universally approved for coltivirus infections; supportive care protocols derive from clinical practice guidelines produced by the Infectious Diseases Society of America and critical care societies at institutions like Cleveland Clinic. Prevention emphasizes personal protective measures promoted by public health campaigns run by state departments and the Centers for Disease Control and Prevention, tick control programs advocated by entomologists at land management agencies such as the United States Forest Service, and habitat interventions informed by conservation biologists at the National Park Service. Vaccine research has been explored in preclinical studies at academic centers including the University of Texas and pharmaceutical collaborations reported in peer-reviewed journals.
The prototype disease, Colorado tick fever, was characterized in epidemiologic studies from early 20th-century fieldwork in Colorado and later consolidated in surveillance reports by state health departments and the Centers for Disease Control and Prevention. Subsequent detections in parts of Asia and Europe prompted investigations by international research consortia involving laboratories at the Pasteur Institute and national institutes in Japan and Russia. Notable case series and outbreak reports have appeared in publications affiliated with the Mayo Clinic and academic medical centers such as University of California, San Diego, influencing vector-borne disease policy deliberations at the World Health Organization and national public health agencies.